A detailed history of Met Life Investment Management, LLC transactions in Biote Corp. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 16,582 shares of BTMD stock, worth $100,155. This represents 0.0% of its overall portfolio holdings.

Number of Shares
16,582
Previous 7,239 129.06%
Holding current value
$100,155
Previous $54,000 70.37%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$5.33 - $8.36 $49,798 - $78,107
9,343 Added 129.06%
16,582 $92,000
Q2 2024

Aug 13, 2024

BUY
$5.44 - $7.47 $39,380 - $54,075
7,239 New
7,239 $54,000

Others Institutions Holding BTMD

About biote Corp.


  • Ticker BTMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Care Facilities
  • Shares Outstandng 7,574,270
  • Market Cap $45.7M
  • Description
  • biote Corp. operates in medical practice-building business within the hormone optimization space. The company offers a platform for Biote-certified practitioners to optimize imbalances in their patient's hormone, vitamin, and mineral levels, as well as prescribe bioidentical hormone therapies and recommend dietary supplements. It also sells Biot...
More about BTMD
Track This Portfolio

Track Met Life Investment Management, LLC Portfolio

Follow Met Life Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.